The goal of the Biostatistics Shared Resource of the UNMC Eppley Cancer Center is to participate in the research mission of the institution by making the expertise and experience of its personnel available to Cancer Center members for planning, conducting and reporting of basic, translational, clinical, and population-based research projects. James C. Lynch, Ph.D., and Jane L. Meza, Ph.D serve as the co-directors of the facility. Dr. Lynch has directed the Biostatistics Shared Resource since its establishment and serves as a member of the Scientific Review Committee. Dr. Lynch is also a Senior Statistician for the Non- Hodgkin Lymphoma Committee of the Children's Oncology Group. As Co-Director for the Biostatistics Shared Resource, Dr. Lynch serves as the primary statistician for the Scientific Review Committee. Dr. Meza, became Co-Director of the Biostatistics Shared Resource in 2008. She is the Director of the Biostatistics Core for the Cancer Center's Specialized Program of Research Excellence (SPORE) in pancreatic cancer and Director for the Center for Collaboration on Research Design and Analysis. Dr. Meza is also a Senior Statistician for the Children's Oncology Group, working with the Cancer Control, Nursing and Soft Tissue Sarcoma committees. Drs. Lynch and Meza serve as the primary contacts between the Biostatistics Share Resource and the Cancer Center.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA036727-28
Application #
8710018
Study Section
Subcommittee B - Comprehensiveness (NCI)
Project Start
Project End
Budget Start
2014-08-01
Budget End
2015-07-31
Support Year
28
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Nebraska Medical Center
Department
Type
DUNS #
City
Omaha
State
NE
Country
United States
Zip Code
68198
Xie, Shuwei; Bahl, Kriti; Reinecke, James B et al. (2016) The endocytic recycling compartment maintains cargo segregation acquired upon exit from the sorting endosome. Mol Biol Cell 27:108-26
Hanson, Ryan L; Brown, Roger B; Steele, Maria M et al. (2016) Identification of FRA-1 as a novel player in pancreatic cancer in cooperation with a MUC1: ERK signaling axis. Oncotarget 7:39996-40011
Hill, Tanner K; Mohs, Aaron M (2016) Image-guided tumor surgery: will there be a role for fluorescent nanoparticles? Wiley Interdiscip Rev Nanomed Nanobiotechnol 8:498-511
Pai, Priya; Rachagani, Satyanarayana; Dhawan, Punita et al. (2016) MUC4 is negatively regulated through the Wnt/β-catenin pathway via the Notch effector Hath1 in colorectal cancer. Genes Cancer 7:154-68
Spagnol, Gaelle; Kieken, Fabien; Kopanic, Jennifer L et al. (2016) Structural Studies of the Nedd4 WW Domains and Their Selectivity for the Connexin43 (Cx43) Carboxyl Terminus. J Biol Chem 291:7637-50
Hill, Tanner K; Davis, Amanda L; Wheeler, Frances B et al. (2016) Development of a Self-Assembled Nanoparticle Formulation of Orlistat, Nano-ORL, with Increased Cytotoxicity against Human Tumor Cell Lines. Mol Pharm 13:720-8
Wuebben, Erin L; Wilder, Phillip J; Cox, Jesse L et al. (2016) SOX2 functions as a molecular rheostat to control the growth, tumorigenicity and drug responses of pancreatic ductal adenocarcinoma cells. Oncotarget 7:34890-906
Kelkar, Sneha S; Hill, Tanner K; Marini, Frank C et al. (2016) Near infrared fluorescent nanoparticles based on hyaluronic acid: Self-assembly, optical properties, and cell interaction. Acta Biomater 36:112-21
Marr, Alissa S; Zhang, Chi; Ganti, Apar Kishor (2016) Resected small cell lung cancer-time for more? J Thorac Dis 8:E755-7
Fox, Raymond G; Lytle, Nikki K; Jaquish, Dawn V et al. (2016) Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma. Nature 534:407-11

Showing the most recent 10 out of 1236 publications